25 results found.

Colorectal Neoplasms Clinical Trial using Regorafenib (BAY73- 4506)

Bayer - Recruiting 18 years or older.
- An Open-label Phase III Study of Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard Therapy.
Regorafenib (BAY73- 4506)

Colorectal Neoplasms Clinical Trial using Samples and follow up

Centre Hospitalier Universitaire de NÄ«mes - Recruiting 18 years or older.
- Invasiveness and Chemoresistance of Cancer Stem Cells in Colon Cancer: Molecular Characterization and Implications for Therapeutic Strategies.
Samples and follow up

Colorectal Neoplasms, Esophageal Neoplasms, or Ovarian Neoplasms Clinical Trial using Indomethacin

UMC Utrecht - Recruiting 18 years to 70 years.
- Phase I Study Evaluating Indomethacin in Combination With Platinum-based Chemotherapy.
Indomethacin

Lung or Prostatic Neoplasms, Colorectal or Kidney Neoplasms, Panc Clinical Trial using NK cells +CliniMACs CD3 and CD56 systems

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 70 years.
- Safety and the Anti-Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK TRAIL Cytotoxicity With Bortezomib.
NK cells +CliniMACs CD3 and CD56 systems

Colorectal Neoplasms, Gastric Neoplasms, Cholangiocarcinoma, Bile Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 90 years.
- Tumor, Normal Tissue and Specimens From Patients Undergoing Evaluation or Surgical Resection of Solid Tumors.

Colorectal Neoplasms Clinical Trial using folic acid; folic acid calcium vitamin D3; calcium

Shanghai Jiao Tong University School of Medicine - Recruiting 50 years to 80 years.
- A Randomize Controlled Trial of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer.
folic acid; folic acid calcium vitamin D3; calcium

Colorectal Neoplasms Clinical Trial using Regorafenib (Stivarga, BAY73-4506); Placebo

Bayer - Recruiting 18 years or older.
- A Randomized, Double-blind, Placebo-controlled Phase-III Study of Adjuvant Regorafenib Versus Placebo for Patients With Stage IV Colorectal Cancer After Curative Treatment of Liver Metastases.
Regorafenib (Stivarga, BAY73-4506); Placebo

Colorectal Neoplasms Clinical Trial using Endoscopic submucosal dissection; Laparoscopic resection

Chinese University of Hong Kong - Recruiting 18 years or older.
- Endoscopic Submucosal Dissection Versus Laparoscopic Resection for Early Colorectal Neoplasms: A Prospective Randomized Trial.
Endoscopic submucosal dissection; Laparoscopic resection

Colorectal Neoplasms Clinical Trial using Capecitabine

Sun Yat-sen University - Recruiting 18 years to 80 years.
- Phase II Clinical Trial: Capecitabine Maintenance Therapy in Colorectal Cancer Patients With Stage IIIC and R0-R1 Resected Stage IV.
Capecitabine

Prostatic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Mela Clinical Trial using Interactive Voice Response (IVR) Reminders

Michigan State University - Recruiting 21 years or older.
- Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR.
Interactive Voice Response (IVR) Reminders

Neoplasms, Neoplasm Metastasis, Melanoma, Carcinoma, Non-Small-Ce Clinical Trial using LY3009120 capsule

Eli Lilly and Company - Recruiting 18 years or older.
- A Phase 1 Study of LY3009120 in Patients With Advanced or Metastatic Cancer.
LY3009120 capsule

Colorectal Neoplasms Clinical Trial using Geriatric intervention

Oslo University Hospital - Recruiting 65 years or older.
- Geriatric Intervention in Elderly Surgical Patients With Colorectal Cancer - a Randomized, Controlled Trial..
Geriatric intervention

Colorectal Neoplasms, Colorectal Carcinoma, or Colorectal Tumors Clinical Trial using ISIS 183750; Irinotecan

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Phase I/II Study of ISIS 183750 in Combination With Irinotecan in Irinotecan-refractory Colorectal Cancer.
ISIS 183750; Irinotecan

Colorectal Neoplasms Clinical Trial using BAY73-4506_Regorafenib

Bayer - Recruiting N/A or older.
- Drug Use Investigation of Regorafenib/ STIVARGA for Unresectable, Metastatic or Recurrent Colorectal Cancer.
BAY73-4506_Regorafenib

Appendix Cancer, or Colorectal Cancer Clinical Trial using Cytoreductive Surgery; HIPEC with Mitomycin-C; EPIC with FUDR and Leucovorin

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- ICARuS (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Single-center, Randomized Phase II Trial of Early Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis.
Cytoreductive Surgery; HIPEC with Mitomycin-C; EPIC with FUDR and Leucovorin

Colorectal Neoplasms Clinical Trial using Eflornithine placebo & sulindac placebo; eflornithine & sulindac placebo; Eflornithine placebo & sulindac; Eflornithine plus sulindac

Southwest Oncology Group - Recruiting 18 years or older.
- A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES).
Eflornithine placebo & sulindac placebo; eflornithine & sulindac placebo; Eflornithine placebo & sulindac; Eflornithine plus sulindac

Colorectal Neoplasms Clinical Trial using Nadroparin; Placebo

Fudan University - Recruiting 18 years to 80 years.
- Study of The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Colorectal Cancer.
Nadroparin; Placebo

Colorectal Neoplasms Clinical Trial using Optimized ESD with snaring; Conventional ESD

Asan Medical Center - Recruiting 18 years or older.
- Comparison of Coventional Endoscopic Submucosal Dissection and Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal Neoplasm.
Optimized ESD with snaring; Conventional ESD

Colorectal Neoplasms, or Metastatic Disease Clinical Trial using Regorafenib

Spanish Cooperative Group for Digestive Tumour Therapy (TTD) - Recruiting 18 years or older.
- A Phase II Study of Single-agent Regorafenib in the First Line Treatment of Frail and/or Unfit for Polychemotherapy Patients With Metastatic Colorectal Cancer (mCRC).
Regorafenib

Secondary Malignant Neoplasm of Liver, or Colorectal Neoplasms Clinical Trial using Open liver resection; Laparoscopic liver resection

Oslo University Hospital - Recruiting 18 years or older.
- Prospective Randomized Study of Laparoscopic Versus Open Liver Resection for Colorectal Metastases.
Open liver resection; Laparoscopic liver resection

Colorectal Neoplasms, Neoplasm Metastasis, or Liver Neoplasms Clinical Trial using Cetuximab; chemotherapy of mFOLFOX6 or FOLFIRI

Fudan University - Recruiting 18 years to 75 years.
- Study of Cetuximab in Combination With Chemotherapy for the First Treatment of Metastatic Colorectal Cancer.
Cetuximab; chemotherapy of mFOLFOX6 or FOLFIRI

Colorectal Neoplasms Clinical Trial using sorafenib; FOLFIRI

Fudan University - Recruiting 18 years to 75 years.
- A Phase ? Open Label, Non Randomized Study, in Which Sorafenib is Used in Combination With Irinotecan, Leucovorin and Fluorouracil in Patients With Advanced Colorectal Cancer After Failure of Oxaliplatin Treatment.
sorafenib; FOLFIRI

Colonic Neoplasms Clinical Trial using Therapeutic conventional colorectal surgery; Therapeutic laparoscopic colorectal surgery; Peripheral blood sampling and performing: ELISA test of sFas, sFasL, IL - 17 and Bursttest

University Hospital Dubrava - Recruiting 20 years to 80 years.
- Double Blinded Randomized Clinical Trial of the Effect of Open Versus Laparoscopic Colectomy on Neutrophils in Patients With Colon Cancer.
Therapeutic conventional colorectal surgery; Therapeutic laparoscopic colorectal surgery; Peripheral blood sampling and performing: ELISA test of sFas, sFasL, IL - 17 and Bursttest

Colonic Neoplasms Clinical Trial

Samsung Medical Center - Recruiting N/A or older.
- Establishing Effective Screening Methods for Diagnosing Hereditary Nonpolypoisis Colorectal Cancer.

Colorectal Cancer, Liver Neoplasms, Hepatocellular Carcinoma, Gal Clinical Trial using interventionally implanted hepatic arterial port catheter

Charite University, Berlin, Germany - Recruiting 18 years or older.
- Open One-Arm Therapy Optimizing Trial on Regional Chemotherapy of the Liver Through an Interventionally Implanted A.Hepatica Port System in Patients With Liver Metastases or Primary Liver Neoplasms..
interventionally implanted hepatic arterial port catheter